ACB
$1.430 (1.42%)
ACNNF
$0.030 (0%)
AERO
$3.210 (0%)
ALEAF
$0.050 (-14.97%)
AMMJ
$0.048 (12.81%)
APHA
$15.380 (0%)
ARNA
$99.990 (0%)
ATT:CNX
$0.080 (0%)
AUSA:CNX
$0.065 (0%)
AUSAF
$0.050 (0%)
AVXL
$11.060 (-0.98%)
BAMM:CNX
$0.130 (0%)
BBM:CNX
$0.030 (-14.29%)
BBRRF
$0.027 (-3.27%)
BE:CNX
$0.005 (0%)
BIO:CNX
$0.013 (0%)
BLIS:CNX
$0.315 (0%)
BLO:CNX
$0.395 (2.6%)
BLOZF
$0.308 (2.5%)
BUDZ
$0.100 (-9.09%)
CADMF
$0.052 (0%)
CALI:CNX
$0.085 (13.33%)
CANN
$0.230 (-2.13%)
CARA
$9.060 (-6.69%)
CBWTF
$0.062 (0.16%)
CGC
$2.540 (-0.97%)
CGRW
$0.016 (-22%)
CHOO:CNX
$0.005 (0%)
CHOOF
$0.003 (-16%)
CNBX
$3.990 (0%)
CNGGF
$0.203 (0%)
CODI
$22.680 (0.22%)
CPMD
$0.020 (-4.81%)
CRBP
$0.281 (0.07%)
CRON
$3.050 (0.33%)
CROP:CNX
$0.015 (0%)
CSI:CNX
$0.070 (-12.5%)
CURR
$0.349 (2.65%)
CVSI
$0.033 (7.49%)
DIGP
$0.014 (0%)
EEVVF
$0.078 (0%)
EMHTF
$0.039 (10.17%)
EPWCF
$0.059 (0%)
FFT:CNX
$0.040 (0%)
FNNZF
$0.075 (13.64%)
GNBT
$0.001 (0%)
GRIN:CNX
$0.075 (-16.67%)
GRWG
$4.840 (-1.83%)
GTBIF
$10.150 (-1.46%)
GTII:CNX
$13.090 (-1.65%)
GWPH
$218.960 (0%)
HEXO
$0.196 (-0.56%)
HHPHF
$0.079 (0%)
HLSPY
$0.363 (0%)
HMLSF
$2.800 (0%)
HMPPF
$0.498 (0%)
HRVOF
$0.023 (-11.07%)
HSTRF
$0.135 (0%)
HUGE:CNX
$1.180 (-1.67%)
IAN:CNX
$0.075 (0%)
IGC
$0.520 (-3.02%)
IGXT
$0.219 (13.76%)
IIPR
$92.910 (-2.5%)
INQD
$0.009 (-3.23%)
IONC:CNX
$0.005 (0%)
IONKF
$0.005 (-2.04%)
ISOL:CNX
$0.035 (0%)
ITHUF
$0.062 (5.65%)
KBEV:CNX
$0.045 (0%)
KHRNF
$0.091 (-2.15%)
KSHB
$0.695 (0%)
LHS:CNX
$1.470 (0%)
LHSIF
$1.145 (0%)
LXX:CNX
$8.400 (0%)
MCIG
$0.028 (0%)
MEDIF
$0.057 (1.15%)
MGWFF
$0.060 (9.57%)
MJ:CNX
$0.050 (0%)
MJNA
$0.015 (1.4%)
MNTR
$0.040 (0%)
MYM:CNX
$0.140 (0%)
MYMMF
$0.106 (0%)
NCNNF
$0.058 (0%)
NDVAF
$0.111 (-6.17%)
NGW:CNX
$0.410 (0%)
NRXCF
$0.035 (0%)
NSPDF
$0.010 (-23.53%)
NVTQF
$0.596 (0%)
NWKRF
$0.424 (0%)
NXGWF
$0.316 (0%)
NXTTF
$0.033 (6.61%)
OH:CNX
$5.330 (0%)
ORHOF
$4.050 (0%)
PHCG
$0.001 (0%)
PHVAF
$0.038 (0%)
PILL:CNX
$0.230 (-17.86%)
PKG:CNX
$0.020 (-20%)
PLPRF
$0.357 (0%)
PLUS:CNX
$0.440 (0%)
PMCB
$2.420 (0%)
PNPL
$0.012 (0%)
PTNYF
$0.018 (3.24%)
QCA:CNX
$0.095 (-5%)
RDDTF
$0.020 (1.53%)
RLLVF
$0.001 (0%)
RMHB
$0.028 (2.8%)
RQB:CNX
$0.005 (0%)
RQHTF
$0.448 (2.99%)
SLNG:CNX
$0.095 (-9.52%)
SMG
$83.180 (-1.21%)
SNN:CNX
$0.155 (0%)
SOL:CNX
$0.320 (0%)
SOLCF
$0.250 (0%)
SPLIF
$0.016 (-15.79%)
SPRWF
$0.268 (0%)
STEM:CNX
$0.035 (0%)
STMH
$0.028 (1.45%)
SUN:CNX
$0.150 (0%)
TBPMF
$0.052 (3.82%)
TCAN:CNX
$0.135 (0%)
TCNAF
$0.080 (0%)
TER:CNX
$3.480 (-0.57%)
TGEN
$1.200 (0%)
TGIF:CNX
$0.025 (-16.67%)
TGIFF
$0.020 (-12.28%)
THC:CNX
$0.048 (0%)
THCBF
$0.044 (12.85%)
TLRY
$3.540 (1.14%)
TRLFF
$0.035 (0%)
TRSSF
$2.710 (0.37%)
TURV
$0.001 (0%)
VIDA:CNX
$0.055 (0%)
VIN:CNX
$0.015 (0%)
VPRB
$0.047 (-6%)
VRTHF
$0.026 (0%)
VVCIF
$0.035 (-8.14%)
WAYL:CNX
$0.740 (0%)
XXII
$1.740 (-12.12%)
ZDPY
$0.740 (-2.63%)
ZYNE
$1.190 (-0.83%)
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is pleased to reveal a new transformative marketing campaign of its prestige Lord Jones™ brand. Adding another milestone to its legacy as a “brand of firsts,” Lord Jones™, maker of the world’s finest hemp-derived CBD infused products, today announced its first brand campaign…
Earlier this week, the rumor mill started to imply that the merger between Aphria, Inc. (APHA.TO) (APHA) and Tilray, Inc. (TLRY) could be in trouble. The basis of the opinion is related to how Tilray extended the date of the shareholder meeting and lowered the bar to pass amendments. Previously,…
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, CBD and vaporization device company, today announced Southern Glazer's Wine & Spirits, the world's pre-eminent distributor of beverage alcohol, as the distribution partner for its U.S. portfolio of CBD-infused beverages. This partnership announcement follows the recent launch of Quatreau…
Earlier this week, Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) reported a major milestone and formed an agreement with Arizona's largest cannabis wholesaler, Copperstate Farms Management, through its majority owned subsidiary ALPS. We are bullish on the relationship with Copperstate Farms and consider it to be a potential major revenue…
Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF) and its indirect wholly-owned subsidiary Hifyre Inc., today announced the milestone achievement of 250,000 Spark Perks TM members across the Fire & Flower retail network. Spark Perks members receive special benefits where permitted, including: Spark Fastlane TM click-and-collect checkout, personalized recommendations, curbside…
The Democrats are working to follow through on campaign promises from the 2020 election as it relates to cannabis legalization or decriminalization. Earlier this week, the House of Representatives voted in favor of a bipartisan bill to protect banks that service state-legal cannabis businesses from being penalized by federal regulators.…
For decades, April 20th has been a holiday for cannabis consumers and demand this year is expected to be high. The holiday started in the early 1970s when five friends from a California high school who were collectively called the Waldo’s decided to meet at 4:20 to indulge in their…
One of the biggest surprises of the 2020 US general election is related to the number of conservative states that passed legislation to legalize medical and/or recreational cannabis. The Green Rush in the US is starting to accelerate as states like Arizona and New York pass measures to legalize recreational…
GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines, today announces that the European Commission (EC) has approved the Type II variation application for EPIDYOLEX® (cannabidiol) as an adjunctive treatment of seizures associated with TSC, for…
Parallel, one of the largest privately-held multi-state cannabis operators in the United States (U.S.), today announced it will make a $25 million dollar investment in a new state-of-the art cannabis cultivation, production and retail facility in Texas . This financial commitment expands Parallel's ability to meet the growing patient demand…